SIREN : 449985266
PHARMACIE PONT NEUF is a French company founded 22 years ago, specialized in the sector Services administratifs combinés de bureau. Based in SAINT-LOUIS (97450), this company of category PME shows in 2019 a revenue of 252 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | 251 745 € | 2 646 783 € |
| Net income | -121 640 € | -177 052 € | -171 149 € | 1 022 907 € | -69 830 € |
| EBITDA | -121 639 € | -175 437 € | -260 008 € | -233 808 € | -59 559 € |
| Net margin | N/C | N/C | N/C | 406.3% | -2.6% |
In 2022, PHARMACIE PONT NEUF records a net loss of 122 k€. This deficit will reduce equity on the balance sheet.
-121 639 €
-121 640 €
-121 640 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 93%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.04%
92.989%
-0.003
In 2022, the debt ratio of PHARMACIE PONT NEUF (0.04) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2022, the financial autonomy of PHARMACIE PONT NEUF (93.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2022, the repayment capacity of PHARMACIE PONT NEUF (-0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 588.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
588.501
0.0
In 2022, the liquidity ratio of PHARMACIE PONT NEUF (588.50) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2022, the interest coverage of PHARMACIE PONT NEUF (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 359 days. Excellent situation: suppliers finance 359 days of the operating cycle (retail model).
0 €
0 j
359 j
0 j
Compare PHARMACIE PONT NEUF with other companies in the same sector:
Voir toutes les statistiques du secteur Services administratifs combinés de bureau
The revenue of PHARMACIE PONT NEUF in 2019 is 252 k€.
PHARMACIE PONT NEUF recorded a net loss in 2022.
The headquarters of PHARMACIE PONT NEUF is located in SAINT-LOUIS (97450), in the department La Reunion.
The tax return of PHARMACIE PONT NEUF is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHARMACIE PONT NEUF operates in the sector Services administratifs combinés de bureau (NAF code 82.11Z). See the 'Sector positioning' section above to compare the company with its competitors.